ZA200407794B - Novel biomaterials, their preparation and use. - Google Patents

Novel biomaterials, their preparation and use.

Info

Publication number
ZA200407794B
ZA200407794B ZA200407794A ZA200407794A ZA200407794B ZA 200407794 B ZA200407794 B ZA 200407794B ZA 200407794 A ZA200407794 A ZA 200407794A ZA 200407794 A ZA200407794 A ZA 200407794A ZA 200407794 B ZA200407794 B ZA 200407794B
Authority
ZA
South Africa
Prior art keywords
preparation
novel biomaterials
biomaterials
novel
Prior art date
Application number
ZA200407794A
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejtli
Gyoergy Lajos Kis
Christian Schoch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200407794B publication Critical patent/ZA200407794B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ZA200407794A 2002-04-19 2004-09-28 Novel biomaterials, their preparation and use. ZA200407794B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19

Publications (1)

Publication Number Publication Date
ZA200407794B true ZA200407794B (en) 2006-02-22

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200407794A ZA200407794B (en) 2002-04-19 2004-09-28 Novel biomaterials, their preparation and use.

Country Status (20)

Country Link
US (3) US20050163853A1 (fr)
EP (1) EP1499361B1 (fr)
JP (1) JP4648632B2 (fr)
KR (1) KR101121675B1 (fr)
CN (1) CN1646171B (fr)
AU (1) AU2003224099B2 (fr)
BR (1) BR0309340A (fr)
CA (1) CA2484100C (fr)
CO (1) CO5611168A2 (fr)
ES (1) ES2392964T3 (fr)
HK (1) HK1073070A1 (fr)
IL (1) IL164627A (fr)
MX (1) MXPA04010325A (fr)
NO (1) NO20044979L (fr)
NZ (1) NZ535810A (fr)
PL (1) PL215579B1 (fr)
PT (1) PT1499361E (fr)
RU (1) RU2321597C2 (fr)
WO (1) WO2003089008A1 (fr)
ZA (1) ZA200407794B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
AU2005209201B2 (en) * 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
WO2006011044A1 (fr) * 2004-07-22 2006-02-02 Pfizer Products Inc. Compositions a base de cyclodextrine amorphe
US20060089590A1 (en) * 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
EP1787658B1 (fr) 2005-11-10 2012-03-14 CHEMI S.p.A. Formulations à libération prolongée contenant des inhibiteurs de l'hormone de croissance analogues de la somatostatine
CN101501484B (zh) * 2006-09-04 2012-12-26 独立行政法人产业技术综合研究所 通过毛细管电泳法分析试样的方法
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
US8137512B2 (en) * 2006-09-04 2012-03-20 National Institute Of Advanced Industrial Science And Technology Process for analyzing sample by capillary electrophoresis method
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
CN102421451B (zh) 2009-02-25 2013-11-06 休普拉特克药品有限公司 苯达莫司汀环多糖组合物
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
EP2547221B1 (fr) 2010-03-13 2014-12-17 Eastpond Laboratories Limited Compositions fixant les graisses
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
JP2014502612A (ja) 2010-12-31 2014-02-03 イーストポンド・ラボラトリーズ・リミテッド シクロデキストリンを含有する細胞水和組成物
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
BR112013018933A2 (pt) * 2011-02-10 2016-09-13 Unilever Nv composições antiviral, antisséptica líquida, e sólida para a lavagem pessoal, de limpeza sólida e líquida da superfície rígida, antimicrobiana, higienizadora de mãos, método de desinfecção de uma superfície e utilização de uma composição
EP2804915B1 (fr) 2012-01-18 2016-03-30 SurModics, Inc. Revêtement de dispositif médical lubrifié à faibles particules
CA2932532C (fr) * 2012-12-04 2021-06-22 Phosphorex, Inc. Microparticules et nanoparticules ayant des charges de surface negatives
US20160096931A1 (en) * 2013-05-17 2016-04-07 Marquette University Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
US20180369124A1 (en) 2015-06-24 2018-12-27 Kao Germany Gmbh Hair treatment process
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
WO2018075614A1 (fr) 2016-10-18 2018-04-26 Marquette University Matériaux composites contenant des polymères structuraux et des agents de libération d'oxyde nitrique photoréactifs et leurs utilisations pour pansements de plaies
EP4132294A1 (fr) 2020-04-06 2023-02-15 Eastpond Laboratories Limited Compositions favorisant l'hydratation cellulaire
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
WO2023212740A1 (fr) * 2022-04-29 2023-11-02 Drexel University Tissu revêtu de mof imprégné de tensioactif pour applications antimicrobiennes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (fr) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (fr) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation de peptides hydrosolubles
CA2328092A1 (fr) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Procede servant a isoler des polysaccharides mucilagineux et leurs utilisations
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
MXPA02011254A (es) * 2000-05-15 2003-03-10 Procter & Gamble Composiciones que comprenden ciclodextrina.
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
PL215579B1 (pl) 2013-12-31
NZ535810A (en) 2007-11-30
CN1646171A (zh) 2005-07-27
HK1073070A1 (en) 2005-09-23
EP1499361B1 (fr) 2012-08-08
EP1499361A1 (fr) 2005-01-26
KR20040103968A (ko) 2004-12-09
ES2392964T3 (es) 2012-12-17
CA2484100A1 (fr) 2003-10-30
CA2484100C (fr) 2012-01-03
MXPA04010325A (es) 2005-06-08
PT1499361E (pt) 2012-11-22
AU2003224099B2 (en) 2006-11-09
PL371595A1 (en) 2005-06-27
WO2003089008A1 (fr) 2003-10-30
AU2003224099A1 (en) 2003-11-03
CN1646171B (zh) 2010-05-26
JP4648632B2 (ja) 2011-03-09
IL164627A0 (en) 2005-12-18
RU2004133887A (ru) 2005-10-20
BR0309340A (pt) 2005-03-08
NO20044979L (no) 2004-11-16
IL164627A (en) 2009-11-18
US20120040901A1 (en) 2012-02-16
US20080299166A1 (en) 2008-12-04
CO5611168A2 (es) 2006-02-28
US20050163853A1 (en) 2005-07-28
JP2005529879A (ja) 2005-10-06
RU2321597C2 (ru) 2008-04-10
KR101121675B1 (ko) 2012-03-13

Similar Documents

Publication Publication Date Title
ZA200407794B (en) Novel biomaterials, their preparation and use.
TWI371450B (en) Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
ZA200201806B (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof.
MX248882B (es) Composiciones, polimeros y metodos para fijacion del cabello.
ZA200103580B (en) Aluminosilicate compositions, preparation and use.
EP1617807A4 (fr) 1,4-diazepines substituees et leurs utilisations
ZA200501431B (en) 5-Aryltetrazole compounds, compositions thereof, and uses therefor.
MXPA03009167A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
MXPA03009204A (es) PRODUCTO ABSORBENTE CON ADAPTACIoN MEJORADA.
AU2003217565A8 (en) Polydioxaborines, their monomers and their preparation
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
EP1517879A4 (fr) Aminoalkylphenols et leurs procedes d'utilisation et de fabrication
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
GB0305089D0 (en) Composition, use and process
ZA200109571B (en) Novel compounds, their use and preparation.
AU2003299336A8 (en) Diphosphines, preparation and uses thereof
EP1660088A4 (fr) Pyridomorphinanes, pyridazinomorphinanes et utilisation associee
MXPA03007550A (es) Derivados coloporosidos, proceso para su preparacion y su uso.
MXPA02005784A (es) Cepillo de dientes, estruche-mango para el mismo y soporte para dicho cepillo de dientes.
GB0229445D0 (en) Process,composition and use
GB0326138D0 (en) Polymers, their preparation and uses
GB2420345B (en) 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use